Related Experiment Video
Updated: May 27, 2026
05:07
Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
[Unilateral generalized morphea: a case and literature review]
Antonia M Fernández Rodríguez1, Myriam Gandia Martínez, Natalia Navas García
1Sección de Reumatología, Hospital Universitario Puerta del Mar, Cádiz, España. amfernandezr@yahoo.es
Reumatologia Clinica
|November 15, 2011
Summary
Localized scleroderma, a connective tissue disorder, can cause severe complications. Unilateral generalized morphea, an extremely rare variant, is presented in a case study of a young girl.
Area of Science:
- Dermatology
- Rheumatology
- Connective Tissue Diseases
Background:
- Localized scleroderma is a connective tissue disorder affecting the dermis and subcutaneous tissue.
- It can lead to complications like indurated plaques, growth retardation, and muscle atrophy.
- Unilateral generalized morphea is a rare variant with limited reported cases.
Observation:
- The case involves a young girl presenting with unilateral generalized morphea.
- The condition was specifically observed on the right side of her body.
Findings:
- This report details an extremely rare case of unilateral generalized morphea.
- The patient developed the condition on one side of her body.
Implications:
- This case contributes to the limited literature on unilateral generalized morphea.
- Understanding this rare variant is crucial for diagnosis and management of localized scleroderma.
- Further research may elucidate the specific mechanisms and treatment for this subtype.
Related Concept Videos
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...